| Tumor-infiltrating mast cells are associated with resistance to anti-PD-1 therapy R Somasundaram, T Connelly, R Choi, H Choi, A Samarkina, L Li, ... Nature communications 12 (1), 346, 2021 | 123 | 2021 |
| Very low mutation burden is a feature of inflamed recurrent glioblastomas responsive to cancer immunotherapy M Gromeier, MC Brown, G Zhang, X Lin, Y Chen, Z Wei, N Beaubier, ... Nature communications 12 (1), 352, 2021 | 91 | 2021 |
| Diverse clonal fates emerge upon drug treatment of homogeneous cancer cells Y Goyal, GT Busch, M Pillai, J Li, RH Boe, EI Grody, M Chelvanambi, ... Nature, 1-9, 2023 | 45 | 2023 |
| NARRMDA: negative-aware and rating-based recommendation algorithm for miRNA–disease association prediction L Peng, Y Chen, N Ma, X Chen Molecular BioSystems 13 (12), 2650-2659, 2017 | 22 | 2017 |
| Melanoma-intrinsic NR2F6 activity regulates antitumor immunity H Kim, Y Feng, R Murad, J Pozniak, C Pelz, Y Chen, B Dalal, R Sears, ... Science Advances 9 (27), eadf6621, 2023 | 2 | 2023 |
| The SET oncoprotein promotes estrogen-induced transcription by facilitating establishment of active chromatin C Guo, KF Meza-Sosa, D Valle-Garcia, G Zhao, K Gao, L Yu, H Zhang, ... Proceedings of the National Academy of Sciences 120 (8), e2206878120, 2023 | | 2023 |
